Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04192630 · ClinicalTrials.gov registry record · NA
A Study of B + L Ophthalmic Viscosurgical Device (OVD) CVisc50
A NA study, sponsored by Bausch & Lomb Incorporated.
- Completed
- Registry status
- NA
- Development phase
- 390
- Enrollment target
NCT04192630 is a NA study that has completed, run by Bausch & Lomb Incorporated. The registered enrollment target is 390 participants.
The verdict
NCT04192630, a NA study, has completed, sponsored by Bausch & Lomb Incorporated.
- COMPLETED
- Registry status
- NA
- Development phase
- 390 participants
- Enrollment target
Study Summary
The objective of the study is to evaluate the safety and effectiveness of the Bausch \& Lomb CVisc50 cohesive OVD compared to the Alcon ProVisc® cohesive OVD when used in cataract surgery.
Interventions
- PROCEDURE Cataract Surgery
- DEVICE CVisc50 OVD
- DEVICE ProVisc OVD
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 390 participants |
| Start Date | 2019-11-26 |
| Est. Completion | 2022-01-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04192630
The ClinicalTrials.gov registry entry for NCT04192630 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 390 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bausch & Lomb Incorporated, which has 174 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Cataract Surgery is the first listed.
NCT04192630 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04192630 about?
NCT04192630 is a clinical study titled "A Study of B + L Ophthalmic Viscosurgical Device (OVD) CVisc50". The objective of the study is to evaluate the safety and effectiveness of the Bausch \& Lomb CVisc50 cohesive OVD compared to the Alcon ProVisc® cohesive OVD when used in cataract surgery.
What is the current status of trial NCT04192630?
This trial is currently completed. It is a NA study. The enrollment target is 390 participants. The study started on 2019-11-26. Estimated completion is 2022-01-31.
What interventions are being tested in trial NCT04192630?
The interventions under investigation include: Cataract Surgery (PROCEDURE), CVisc50 OVD (DEVICE), ProVisc OVD (DEVICE).
Who is sponsoring clinical trial NCT04192630?
This trial is sponsored by Bausch & Lomb Incorporated, which has 174 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.